Capricor Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CAPR Nasdaq 2830 www.capricor.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Capricor Therapeutics, Inc.

Capricor Lawsuit Puts Duchenne Therapy Launch Plans And Valuation In Focus - May 13th, 2026 6:18 am
Capricor Therapeutics Inc (CAPR) Q1 2026 Earnings Call Highlights: Strong Cash Position Amid ... - May 12th, 2026 11:02 pm
Capricor Therapeutics Q1 Earnings Call Highlights - May 12th, 2026 4:08 pm
Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - May 12th, 2026 2:05 pm
Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trial - May 11th, 2026 4:00 am
Capricor's Insider Just Sold Big — Her Options Tell the rest of the Story - May 10th, 2026 5:21 am
A Look At Capricor Therapeutics (CAPR) Valuation After Phase 3 HOPE-3 Duchenne Data And FDA Review Progress - May 8th, 2026 6:28 pm
Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12 - May 4th, 2026 2:05 pm
How Phase 3 HOPE-3 DMD Data And BLA Review At Capricor Therapeutics (CAPR) Has Changed Its Investment Story - Apr 24th, 2026 4:06 am
We're Not Worried About Capricor Therapeutics' (NASDAQ:CAPR) Cash Burn - Apr 24th, 2026 4:05 am
Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting - Apr 22nd, 2026 7:00 am
Caprock Intersects 38.48 g/t Au over 1.6m Included Within a Broader Interval of 2.84 g/t over 23.2m at Destiny - Mar 25th, 2026 5:30 am
Early Warning Press Release - Frank Guillemette Announces Completion of Acquisition of Common Shares of Caprock Mining Corp. - Mar 23rd, 2026 8:50 am
Capricor Therapeutics (CAPR) Reports Positive Phase 3 HOPE-3 Data and $318M 2025 Cash Balance - Mar 17th, 2026 6:01 pm
Is It Too Late To Reassess Capricor Therapeutics (CAPR) After Its Recent 130% Surge? - Mar 14th, 2026 7:08 am
Capricor Therapeutics Inc (CAPR) Q4 2025 Earnings Call Highlights: FDA Milestones and Financial ... - Mar 12th, 2026 9:07 pm
Capricor (CAPR) Q4 2025 Earnings Call Transcript - Mar 12th, 2026 6:50 pm
Capricor Therapeutics Q4 Earnings Call Highlights - Mar 12th, 2026 4:46 pm
Capricor: Q4 Earnings Snapshot - Mar 12th, 2026 2:27 pm
Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - Mar 12th, 2026 2:01 pm